Eli Lilly 's weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving investors more confidence to keep owning the world's most valuable health-care company even after it's been crushing the S & P 500's performance over the past three years.
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.'s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving investors more confidence to keep owning the world's most valuable health-care company even after it's been crushing the S&P 500's performance over the past three years.
Obesity Pharmaceuticals Health Care Industry S&P 500 Index Novo Nordisk A/S Novo Nordisk A/S Eli Lilly And Co Breaking News: Markets Investment Strategy Markets Jim Cramer Stock Takes Business News
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly's Zepbound shows promise as a sleep apnea treatment in late-stage trialsThe pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year.
Source: NBCPhiladelphia - 🏆 569. / 51 Read more »
Eli Lilly’s weight loss drug Zepbound found to reduce sleep apnea, company saysBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA saysThe insatiable demand for weight loss and diabetes drugs is still trouncing supply, even as Eli Lilly and Novo Nordisk work to increase production capacity.
Source: CNBC - 🏆 12. / 72 Read more »
Eli Lilly's weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trialsThe pharmaceutical giant plans to present the trial data at an upcoming medical conference and submit them to the U.S. Food and Drug Administration mid-year.
Source: nbcsandiego - 🏆 524. / 51 Read more »
The Newest Obesity Drug May Also Combat Sleep ApneaNew data from Eli Lilly suggests that Zepbound can help people lose weight and have fewer episodes of obstructive sleep apnea at the same time.
Source: Gizmodo - 🏆 556. / 51 Read more »
Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker saysZepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said Wednesday.
Source: cnnbrk - 🏆 393. / 55 Read more »